What blood tests should be ordered for a patient receiving paliperidone 100 mg intramuscularly every 4 weeks who presents with gynecomastia?

Blood Tests for Gynecomastia in Patients on Paliperidone 100mg IM Monthly

Measure serum prolactin levels as the primary blood test when a patient on paliperidone develops gynecomastia, as paliperidone is strongly associated with hyperprolactinemia-induced gynecomastia. 1, 2, 3

Primary Evaluation

• Serum prolactin is the essential test, as paliperidone causes marked prolactin elevation that directly leads to gynecomastia through inhibition of gonadotropin secretion and altered testosterone-to-estrogen ratios 1, 2, 3
  • Paliperidone shows extremely strong association with gynecomastia (ROR 7.16) in pharmacovigilance data, with hyperprolactinemia as the primary mechanism 3
  • Prolactin levels in paliperidone-treated patients can range from 1500-3996 mIU/L (normal upper limit 500 mIU/L) 2
  • A single morning sample is sufficient for initial assessment 1

Secondary Hormonal Assessment

Measure serum luteinizing hormone (LH) and testosterone levels to establish the mechanism and severity of hypogonadism causing the gynecomastia 1, 4:

• LH levels help differentiate primary versus secondary hypogonadism 1

  • Low or low-normal LH with low testosterone indicates secondary (central) hypogonadism from prolactin suppression 1

• Total testosterone (morning sample, 8-10 AM) and free testosterone by equilibrium dialysis should be measured 1

  • Hyperprolactinemia inhibits kisspeptin, suppressing gonadotropin and subsequently testosterone production 1
  • Boys may present with gynecomastia specifically due to hypogonadism from elevated prolactin 1

• Serum estradiol should be measured in patients presenting with gynecomastia prior to any intervention 1

  • Elevated estradiol-to-testosterone ratio is the direct cause of breast tissue proliferation 4

Additional Endocrine Screening

• Thyroid function tests (TSH, free T4) must be obtained to exclude hypothyroidism as a confounding cause of hyperprolactinemia 1

• Liver function tests and renal function (urea, electrolytes) should be checked, as hepatic or renal impairment can cause hyperprolactinemia independent of medication effects 1

When to Expand Testing

If prolactin remains persistently elevated after repeat measurement (to exclude stress-related elevation), consider 1:

• Repeat prolactin measurement using an indwelling cannula with 2-3 samples at 20-60 minute intervals to differentiate stress from organic disease 1
• Pituitary MRI if total testosterone is <150 ng/dL with low/normal LH, regardless of prolactin level, to exclude non-secreting pituitary adenomas 1
• Follicle-stimulating hormone (FSH) if fertility concerns exist or if considering reproductive health 1

Clinical Context

The 2025 Lancet Psychiatry guidelines specifically recommend monitoring prolactin before starting antipsychotic treatment and at regular intervals 1. Paliperidone ranks among the highest-risk antipsychotics for gynecomastia after risperidone, with 80.81% of antipsychotic-related gynecomastia cases attributed to risperidone and significant cases to paliperidone 3. The mechanism is hyperprolactinemia leading to hypogonadism, which creates an imbalance favoring estrogen effects over androgen effects 1, 4, 5.

Monitoring Algorithm Summary

1. Immediate: Prolactin, LH, total and free testosterone, estradiol
2. Concurrent: TSH, free T4, liver function, renal function
3. If abnormal: Repeat prolactin (stress exclusion), consider pituitary imaging if testosterone <150 ng/dL with low LH
4. If fertility concerns: Add FSH

This approach identifies the hyperprolactinemia driving the gynecomastia while excluding other endocrine causes and establishing the degree of secondary hypogonadism 1, 4.